drugset / Trial / NCT01048866

A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis

NCT01048866

Phase 3 Completed 198 enrolled Reckitt Benckiser Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purposes of this study is to demonstrate the analgesic efficacy of flurbiprofen 8.75 mg lozenge compared to its vehicle lozenge and to demonstrate the safety of the flurbiprofen lozenge throughout the course of treating sore throat due to acute pharyngitis.

Timeline

Start
2009-11
Primary completion
2011-03
Completion
2011-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Flurbiprofen Small molecule 8.75 mg Oral
Background Acetaminophen Small molecule 650 mg

Indications